Clinical and genetic characteristics of familial hypercholesterolemia patients with type 2 diabetes
Dianjun Sun(Harbin Medical University), G. Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Na‐Qiong Wu(Chinese Academy of Medical Sciences & Peking Union Medical College), Shiqi Li(nLIGHT (United States)), Xinyu You, Ying Gao(Sun Yat-sen University), Bingying Zhou(Chinese Academy of Medical Sciences & Peking Union Medical College), Qian Dong(Daiichi Sankyo (United States)), Y. Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), C.-G. Zhu(Chinese Academy of Medical Sciences & Peking Union Medical College), Ye‐Xuan Cao(Chinese Academy of Medical Sciences & Peking Union Medical College), Y.-L. Guo(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 15
Related Papers
HERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor–Mutated Non–Small-Cell Lung Cancer After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Platinum-Based Chemotherapy
|Journal of Clinical Oncology|2023|224
Modified lentiviral globin gene therapy for pediatric β0/β0 transfusion-dependent β-thalassemia: A single-center, single-arm pilot trial
|Cell stem cell|2024|77
Serpina3k lactylation protects from cardiac ischemia reperfusion injury
|Nature Communications|2025|44
Aberrant LYZ expression in tumor cells serves as the potential biomarker and target for HCC and promotes tumor progression via csGRP78
|Proceedings of the National Academy of Sciences|2023|37